Vaiomer
Created in 2011
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
187 1,670Activities
Entity types
Location
516 Rue Pierre et Marie Curie, 31670 Labège, France
Labège
France
Employees
Scale: 11-50
Estimated: 7
SIREN
530022888Engaged corporates
8
1 3Added in Motherbase
5 years, 2 months ago
biotech Value proposition
Pioneer in Blood and Tissue Microbiomes.
Worldwide Expert in Microbiome Profiling from low bacterial biomass samples
Pioneer and expert in blood and tissue microbiota, Vaiomer carries out microbiota studies, in the fields of human and animal health, for preclinical and clinical research, CROs, dermocosmetics, nutraceuticals and pharmaceutical / biotech companies.
We perform microbiota studies from a very wide variety of biological samples (blood, adipose tissue, biopsies, tumors, and more classically skin, saliva, faeces, etc.): DNA extraction, quantification by qPCR, sequencing metagenomics, Bioinformatics, Biostatistics. Upstream and downstream of the studies: support for the experimental design and the drafting of study protocols, then for the interpretation and valuation of the results.
The role of tissue and blood microbiomes in systemic inflammation is studied in a wide variety of pathologies: https://vaiomer.com/microbiome-applications/
Microbiota can interact with compounds. The study of the action of a compound on the microbiota makes it possible to characterize the modulating, protective or toxic effects of the microbiota on the compound, or of the compound on the microbiota.
Taking into account variations in the microbiota also makes it possible to derisk the translation from the animal model to humans: it is a new source of biomarkers of the therapeutic response (responders / non-responders).
We are an expert multidisciplinary team (Scientific / Microbiota, Molecular Biology, Bioinformatics and Biostatistics), have a unique technology for samples of low bacterial biomass and a molecular biology laboratory that can process samples from infected subjects (COVID , HIV...)
Metagenomics, Biomarkers, Microbiome, Sequencing, Microbiota, Bioinformatics, and BiostatisticsOriginal language
Pioneer in Blood and Tissue Microbiomes.
Worldwide Expert in Microbiome Profiling from low bacterial biomass samples
Pioneer and expert in blood and tissue microbiota, Vaiomer carries out microbiota studies, in the fields of human and animal health, for preclinical and clinical research, CROs, dermocosmetics, nutraceuticals and pharmaceutical / biotech companies.
We perform microbiota studies from a very wide variety of biological samples (blood, adipose tissue, biopsies, tumors, and more classically skin, saliva, faeces, etc.): DNA extraction, quantification by qPCR, sequencing metagenomics, Bioinformatics, Biostatistics. Upstream and downstream of the studies: support for the experimental design and the drafting of study protocols, then for the interpretation and valuation of the results.
The role of tissue and blood microbiomes in systemic inflammation is studied in a wide variety of pathologies: https://vaiomer.com/microbiome-applications/
Microbiota can interact with compounds. The study of the action of a compound on the microbiota makes it possible to characterize the modulating, protective or toxic effects of the microbiota on the compound, or of the compound on the microbiota.
Taking into account variations in the microbiota also makes it possible to derisk the translation from the animal model to humans: it is a new source of biomarkers of the therapeutic response (responders / non-responders).
We are an expert multidisciplinary team (Scientific / Microbiota, Molecular Biology, Bioinformatics and Biostatistics), have a unique technology for samples of low bacterial biomass and a molecular biology laboratory that can process samples from infected subjects (COVID , HIV...)
Microbiome analysis in blood and tissues - VAIOMER
Vaiomer provides microbiome analysis services with expertise on blood microbiome, tissue microbiomes and all low bacterial biomass samples.
https://www.vaiomer.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 INRAE Research, Research Services | INRAE Research, Research Services | Other 2 Aug 2024 | | |
 EMBL Research, Research Services | EMBL Research, Research Services | Other 2 Aug 2024 | | |
 CEA Research | CEA Research | Other 2 Aug 2024 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 20 Nov 2023 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 9 Mar 2023 | | |
 Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 4 May 2022 | | |
 La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | Other 11 May 2023 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 4 Jun 2019 26 Mar 2023 | | |